Laurie Barclay, MD Oct. 8, 2002
Most men with prostate cancer want ready access to prostate-specific antigen (PSA) screening, according to the results of a study in the Oct. 3 issue of the British Medical Journal. However, a separate study suggests that aggressive screening leads to aggressive treatment without improving survival.
“Policy makers and politicians, as well as doctors, need to understand why people want wider access to PSA testing, so that they can find better ways of communicating information about risk,” write Alison Chapple and colleagues from the University of Oxford, U.K.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!